Cleared Traditional

K211265 - TFX-LT2000 Therapy Light

K211265 is an FDA 510(k) clearance for TFX-LT2000 Therapy Light, manufactured by Toefx, Inc.. The device is a Class 2 General & Plastic Surgery device with product code PDZ cleared through the Traditional 510(k) pathway after a 570-day FDA review.

K211265 · Toefx, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2022
Decision
570d
Days
Class 2
Risk

K211265 is an FDA 510(k) clearance for the TFX-LT2000 Therapy Light. Classified as Lasers For Temporary Increase Of Clear Nail In Patients With Onychomycosis (product code PDZ), Class II - Special Controls.

Submitted by Toefx, Inc. (Hamilton, CA). The FDA issued a Cleared decision on November 17, 2022 after a review of 570 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General & Plastic Surgery submissions.

View all Toefx, Inc. devices

FDA 510(k) Submission Details - K211265

510(k) Number K211265 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 26, 2021
Decision Date November 17, 2022
Days to Decision 570 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
455d slower than avg
Panel avg: 115d · This submission: 570d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

PDZ Device Classification - Class 2, Special Controls

Product Code PDZ Lasers For Temporary Increase Of Clear Nail In Patients With Onychomycosis
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition For The Temporary Increase Of Clear Nail In Patients With Onychomycosis (e.g., Dermatophytes Trichophyton Rubrum And T Mentagrophytes, And/or Yeasts Candida Albicans, Etc.).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Braunsolutions Regulatory Group
Alexander Braun Henderson

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - PDZ Lasers For Temporary Increase Of Clear Nail In Patients With Onychomycosis

All 10
Devices cleared under the same product code (PDZ) and FDA review panel - the closest regulatory comparables to K211265.
Medicell Mycosis Laser (MCML24004)
K253960 · Medicell Healthcare Co.,LTD · Mar 2026
Onycho Laser V
K241116 · Terasysd&C, Inc. · Jul 2024
AF Laser
K221363 · ShenB Co., Ltd. · Jul 2022
REMY Medical Therapy Laser System
K190034 · Footdocprenur, LLC · May 2019
LIGHTWALKER AT LIGHTWALKER DT LIGHTWALKER ST-E LIGHTWALKER ST-N
K121508 · Fotona D.D. · Dec 2012
FREEDOM ND: YAG LASER SYSTEM
K113843 · Lutronic Corporation · Sep 2012